Top Markets
#1 Verus Coin Verus Coin +45.28%
#2 Status Status +19.17%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#4 GoPlus Security GoPlus Security +16.92%
#5 Wrapped NXM Wrapped NXM +15.51%
#6 Ontology Gas Ontology Gas +11.14%
#7 DMT-NAT DMT-NAT +9.14%
#8 BankrCoin BankrCoin +8.23%
#9 Pons Pons +7.43%
#10 Nesa Nesa +7.39%
Coin of the day
Verus Coin Verus Coin
Settings
Language
ENGLISH
Currency
USD
Theme
NAYA Biosciences, Inc. NAYA Biosciences, Inc.

NAYA Biosciences, Inc.

NAYA
Rank in Stocks #33843
INVO Bioscience operates as a medical device company, focusing on the... INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Share Price
$1.78
Last synced: 2025-05-22
Market Cap
$6.77M
Change (1 day)
-9.18%
Change (1 year)
0.00%
Country
US
Trade NAYA Biosciences, Inc. (NAYA)

Category

Healthcare
Revenue for NAYA Biosciences, Inc. (NAYA)
Revenue in Mar 2025 TTM: $6.59M
According to NAYA Biosciences, Inc. latest financial reports the company's current revenue (TTM) is $6.59M. In 2023 the company made a revenue of $3.02M an increase over the revenue in the year 2022 that was $822.20K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NAYA Biosciences, Inc. from 2006 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $6.59M 0.93%
2024 $6.53M 116.25%
2023 $3.02M 267.38%
2022 $822.20K -80.24%
2021 $4.16M 301.06%
2020 $1.04M -29.92%
2019 $1.48M 199.41%
2018 $494.38K 75.22%
2017 $282.15K 454.30%
2016 $50.90K 335.46%
2015 $11.69K -82.72%
2010 $67.65K 7.03%
2009 $63.20K 66.35%
2008 $38.00K 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 706,493.56%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 391,791.34%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 538,115.43%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 318,363.85%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 98,677.49%
US